Antimicrobial drug resistance (AMR)

AMR is said to be the ability of a microbe to withstand the effects of medication that once might successfully treat the microbe. The word antibiotic resistance (AR or ABR) is a detachment of AMR, as it relates only to the bacteria becoming resistant to antibiotics. Resistant microbes are more problematic to treat, requiring alternative medications or higher doses of antimicrobials. These methodologies may be more expensive, higher toxicity risk or both. Microbes resistant to numerous antimicrobials are called multidrug resistant (MDR). The classes of drug resistance are extensively drug-resistant (XDR) and totally drug- resistant (TDR).

 

  • Mechanism of bacteria exhibiting drug resistance
  • Heteroresistance in multidrug-resistant Gram-negative pathogens
  • Drug resistant monitoring programs(MRSA,VRSA,ESBL,VRA,MRAB)
  • Bacterial strain - Superbugs
  • Global action plan and awareness
  • Cause and Control

Related Conference of Antimicrobial drug resistance (AMR)

February 24-25, 2020

7th International Congress on Infectious Diseases

Berlin, Germany
April 27-28, 2020

7th Global Congress on Rare Diseases & Orphan Drug

Istanbul, Turkey
June 09-10, 2020

10th European Epidemiology and Public Health Congress

Istanbul, Turkey
July 22-23, 2020

10th World Congress on Rare Diseases and Orphan Drugs

Barcelona, Spain
August 19-20, 2020

European Summit on HIV, STD and STIs

Milan, Italy
September 28-29, 2020

13th Global Infections Conference

Singapore
September 28-29, 2020

World Congress on Infectious Diseases and Rare Diseases

Osaka, Japan
October 5-6, 2020

12th Euro-Global Conference on Infectious Diseases

Vienna, Austria

Antimicrobial drug resistance (AMR) Conference Speakers

Recommended Sessions

Related Journals

Are you interested in